Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Risk_Evaluation_and_Mitigation_Strategy
|
| gptkbp:administeredBy |
certified healthcare settings
|
| gptkbp:appliesTo |
gptkb:esketamine
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:associatedWith |
gptkb:Spravato
|
| https://www.w3.org/2000/01/rdf-schema#label |
Spravato REMS
|
| gptkbp:includes |
patient monitoring
patient enrollment pharmacy certification certification of healthcare settings |
| gptkbp:monitors |
dissociation
adverse events abuse and misuse serious sedation |
| gptkbp:notDispensedTo |
patients for home use
|
| gptkbp:oversees |
gptkb:Janssen_Pharmaceuticals
|
| gptkbp:purpose |
ensure safe use of Spravato
|
| gptkbp:requires |
gptkb:FDA
Spravato prescription |
| gptkbp:website |
https://www.spravatorems.com/
|
| gptkbp:bfsParent |
gptkb:Spravato
|
| gptkbp:bfsLayer |
8
|